PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 23 results · Data & Publications · Cardiovascular  · Clear
🔒 Subscribers only
AUTH/3069/9/18
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bayer
The PMCPA Director initiated a complaint (Paragraph 5.1) after a BMJ paper (Goldacre et al, 12 Sept 2018) assessed whether sponsors posted results to the EU Clinical Trials Register (EUCTR) within …
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/2959/5/17
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Patient recruitment ‘finder’s fee’ for market research email (Bayer)
A head of medicines management at a health board complained about an email sent by a market research recruitment agency to a hospital consultant/cardiologist.The email subject referenced a “Finde…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2791/9/15
Data & Publications Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bayer breach over Xarelto leavepiece
An anonymous, non-contactable complainant challenged a Bayer sales leavepiece: “Think NOACs and Renal Impairment in Non-Valvular AF. Think Xarelto” (ref L.GB.12.2014.9153a).The leavepiece inclu…
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2709/4/14
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
GSK v Actelion
GlaxoSmithKline (GSK) complained about Actelion’s promotion of Opsumit (macitentan) for pulmonary arterial hypertension (PAH) using a detail aid (OPS 13/0038) and a leavepiece (OPS 13/0039).The m…
Clauses: NONE
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2646/10/13
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
MSD breached ABPI Code over unclear sponsorship disclosure at public health screening event (Health
An anonymous, non-contactable health professional complained about a public health fair (“Health Mela”) in October 2013 featuring NHS-style health checks (heart disease/diabetes) and other acti…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2403/5/11
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Boehringer Ingelheim press release on Pradaxa
A general practitioner complained about a Daily Mail article (5 April 2011) about Pradaxa (dabigatran).The article described warfarin as “rat poison” and called Pradaxa a “wonder drug”; it …
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2446/10/11
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bayer
An anonymous complainant alleged promotion of Levitra by Bayer.The PMCPA determined the matter was outwith the scope of the Code.No case report was produced.
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2357/9/10
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Boehringer Ingelheim
A general practitioner complained about a Boehringer Ingelheim advertisement for Pradaxa (dabigatran) published in The Pharmaceutical Journal (18 September 2010) (ref DGB1729b).The ad used a balanc…
Clauses: NONE
2010 🔒 Subscribe
🔒 Subscribers only
AUTH/2373/11/10
Data & Publications Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Sanofi-Aventis
A doctor complained about a four-page ‘special report’ on atrial fibrillation published in the Health Service Journal (HSJ) (25 November 2010, pages 17–20).The report carried a prominent Sano…
Clauses: 9.1
2010 🔒 Subscribe
🔒 Subscribers only
AUTH/2345/8/10
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi
A medicines management team leader complained on behalf of a local healthcare consortium about an alleged statement made by a Daiichi-Sankyo representative promoting Olmetec (olmesartan).The allega…
Clauses: NONE
2010 🔒 Subscribe
🔒 Subscribers only
AUTH/2260/9/09
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Boehringer Ingelheim rep emailed misleading/disparaging claims about Xarelto (rivaroxaban)
Boehringer Ingelheim voluntarily admitted that a representative emailed a consultant orthopaedic surgeon with information about Bayer’s Xarelto (rivaroxaban) that could be seen as misleading and …
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2222/4/09
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Lilly & Daiichi-Sankyo
An anonymous Lilly employee complained about a consumer press release (ref UKEFF00062/March 2009) issued jointly by Eli Lilly and Company Limited and Daiichi-Sankyo UK Ltd to mark the UK launch of …
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2095/2/08
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Encysive
Actelion Pharmaceuticals UK Ltd complained about a pilot clinical and cost effectiveness scheme run by Encysive (UK) Limited for Thelin (sitaxentan) in pulmonary arterial hypertension (PAH) patient…
Clauses: NONE
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2192/12/08
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Pfizer voluntary admission
Pfizer voluntarily admitted it had breached the undertaking and assurance given in Case AUTH/2093/1/08 after the Lipitor “fireman” journal advertisement (previously ruled in breach in May 2008)…
Clauses: NONE
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2179/10/08
Data & Publications Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Pfizer
A pharmacist head of prescribing team complained about a Pfizer Lipitor (atorvastatin) mailing (single A4 sheet; ref LIP3086).The mailer headline stated: “Lipitor: an evidence-based choice for lo…
Clauses: 9.1,9.2
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2088/1/08
Data & Publications Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
AstraZeneca breached Clause 9.9 after GP received unsolicited promotional email about Crestor via an
A general practitioner (GP) received an unsolicited email about Crestor (rosuvastatin) to their NHS email address.The GP said they had not knowingly signed up to receive information from AstraZenec…
Clauses: 9.9
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2031/8/07
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
AstraZeneca
A hospital NHS Trust formulary manager complained about an AstraZeneca representative’s conduct promoting Crestor (rosuvastatin).Crestor had been rejected by the Trust’s Drug & Therapeutics…
Clauses: NONE
2007 🔒 Subscribe
🔒 Subscribers only
AUTH/1967/2/07
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis
The head of prescribing and pharmacy services at a primary care trust (PCT) complained that a Novartis representative stated at a surgery that Exforge (amlodipine/valsartan) was endorsed by the PCT…
Clauses: NONE
2007 🔒 Subscribe
🔒 Subscribers only
AUTH/1945/1/07
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis
Novartis voluntarily advised the PMCPA that an advertisement/advertisement feature for amlodipine/valsartan (Exforge), described as “currently in development”, appeared in Hospital Doctor (9 Ja…
Clauses: NONE
2007 🔒 Subscribe
🔒 Subscribers only
AUTH/1858/6/06
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Pharmacist v Pfizer
A pharmacist complained about a The Times article (“Savings on heart drugs attacked as ‘bad medicine’”, 22 June) which included quotations attributed to Pfizer.The article discussed guidanc…
Clauses: NONE
2006 🔒 Subscribe
🔒 Subscribers only
AUTH/1926/12/06
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Lilly
A general practitioner complained that samples of Cialis (tadalafil) were sent to him by post from an agency.The GP said he had not requested the samples; correspondence suggested the agency said i…
Clauses: NONE
2006 🔒 Subscribe
🔒 Subscribers only
AUTH/1866/7/06
Data & Publications Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo voluntary admission after withdrawn Olmetec advert reappeared (breach of undertaking)
Daiichi-Sankyo (formerly Sankyo) voluntarily told the PMCPA that an Olmetec advertisement (OLM 188.1B) previously ruled in breach (AUTH/1787/12/05) had reappeared.The company had given an undertaki…
Clauses: 9.1
2006 🔒 Subscribe
🔒 Subscribers only
AUTH/1854/6/06
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Servier
A principal hospital pharmacist complained that a journal advertisement for Coversyl (perindopril) (ref 06COAD339) had been used again despite a previous ruling against a similar ad (Case AUTH/1756…
Clauses: NONE
2006 🔒 Subscribe
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews